2022
DOI: 10.1038/s41598-022-20834-z
|View full text |Cite
|
Sign up to set email alerts
|

Differential expression of aqueous humor microRNAs in central retinal vein occlusion and its association with matrix metalloproteinases: a pilot study

Abstract: The aim of this study is to investigate the differential expression of microRNAs (miRNAs) in the aqueous humor (AH) of patients with central retinal vein occlusion (CRVO), and their association with AH matrix metalloproteinase (MMP) activity. Eighteen subjects, including 10 treatment naïve patients with CRVO and 8 control subjects, scheduled for intravitreal injection and cataract surgery, respectively, were included. AH samples were collected at the beginning of the procedure. A microarray composed of 84 miRN… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 48 publications
0
1
0
Order By: Relevance
“…This miRNA displayed an average 1.26 log2 fold higher expression in Usher samples and holds potential as a robust biomarker candidate. While miRNA-142-3p has not been previously associated with Usher or sensorineural hearing loss (SNHL), its downregulation has been observed in the aqueous humor of patients with central retinal vein occlusion (CRVO), a condition occasionally linked to retinitis pigmentosa (RP) [75,76].…”
Section: Discussionmentioning
confidence: 99%
“…This miRNA displayed an average 1.26 log2 fold higher expression in Usher samples and holds potential as a robust biomarker candidate. While miRNA-142-3p has not been previously associated with Usher or sensorineural hearing loss (SNHL), its downregulation has been observed in the aqueous humor of patients with central retinal vein occlusion (CRVO), a condition occasionally linked to retinitis pigmentosa (RP) [75,76].…”
Section: Discussionmentioning
confidence: 99%